Peptide Categories

Classification Approaches

Peptides can be classified in several ways, and no single system captures the full complexity of their biology. The three most common approaches are classification by function (what the peptide does), classification by target system (which organ system or pathway it primarily affects), and classification by origin (whether the peptide is naturally occurring in the body or synthetically designed).

Classification by function groups peptides according to their primary biological activity — for example, growth hormone secretagogues, anti-inflammatory agents, or metabolic regulators. Classification by target system organizes peptides according to the physiological system they primarily influence, such as the endocrine system, immune system, or nervous system. Classification by origin distinguishes between endogenous peptides (produced naturally by the body, such as insulin or oxytocin) and synthetic peptides (designed and manufactured in the laboratory, often inspired by or derived from natural sequences).

In practice, many peptides span multiple categories. BPC-157, for instance, has documented effects on tissue healing, gastrointestinal function, and neuroprotection. The categories below represent primary areas of activity and are intended as a navigational aid rather than a strict taxonomy.

Metabolic Peptides

Metabolic peptides primarily target energy balance, glucose homeostasis, and lipid metabolism. The most prominent class within this category is the GLP-1 (glucagon-like peptide-1) receptor agonists, which have transformed the treatment of type 2 diabetes and obesity. These peptides mimic or enhance the incretin effect — the augmented insulin secretion that occurs when glucose is absorbed through the gut rather than administered intravenously.

Newer multi-receptor agonists target not only GLP-1 but also GIP (glucose-dependent insulinotropic polypeptide) and/or glucagon receptors, offering potentially superior efficacy for weight management and metabolic improvement. Research in this category is advancing rapidly, with several novel agents in late-stage clinical trials.

Key peptides in this category include Tirzepatide (a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and obesity), Retatrutide (a triple agonist targeting GIP, GLP-1, and glucagon receptors, currently in clinical trials), and Survodutide (a dual glucagon/GLP-1 receptor agonist being investigated for obesity and metabolic liver disease).

Healing Peptides

Healing peptides promote tissue repair, wound healing, and recovery from injury. These peptides typically work by modulating inflammatory responses, stimulating angiogenesis (new blood vessel formation), promoting cell migration and proliferation, and enhancing extracellular matrix remodeling. They are of particular interest in sports medicine, wound care, and post-surgical recovery research.

The mechanisms through which healing peptides operate are diverse. Some directly stimulate growth factor expression, others modulate nitric oxide signaling or interact with copper-dependent enzymatic processes involved in collagen synthesis and tissue remodeling.

Notable peptides in this category include BPC-157 (Body Protection Compound-157, a pentadecapeptide derived from human gastric juice with extensive preclinical evidence for tissue-protective and healing properties) and GHK-Cu (a copper-binding tripeptide naturally found in human plasma that declines with age, involved in wound healing, collagen synthesis, and skin remodeling).

Growth Hormone Peptides

Growth hormone peptides include GH secretagogues (substances that stimulate growth hormone release from the anterior pituitary) and GHRH (growth hormone-releasing hormone) analogs. Rather than providing exogenous growth hormone directly, these peptides stimulate the body's own production and release mechanisms, which may preserve more physiological pulsatile secretion patterns.

This category encompasses two main classes: GHRH analogs, which act on the GHRH receptor on pituitary somatotrophs, and ghrelin mimetics (GH secretagogues), which act on the growth hormone secretagogue receptor (GHS-R1a). Some peptides in this category also influence IGF-1 (insulin-like growth factor 1) levels, either by stimulating GH release (which drives hepatic IGF-1 production) or by directly modulating IGF-1 pathways.

Key peptides include Tesamorelin (an FDA-approved GHRH analog used for HIV-associated lipodystrophy), Hexarelin (a potent GH secretagogue with additional cardioprotective research interest), GHRP-2 (Growth Hormone Releasing Peptide-2, one of the earlier synthetic GH secretagogues), IGF-1 LR3 (a long-acting analog of insulin-like growth factor 1 with reduced IGF binding protein affinity), and IGF-1 DES (a truncated form of IGF-1 with enhanced potency due to reduced binding protein interaction).

Anti-Aging Peptides

Anti-aging peptides target fundamental processes of biological aging, including telomere shortening, cellular senescence, and age-related decline in regenerative capacity. This is among the more speculative categories, as much of the research is still preclinical, but the underlying biological rationale is compelling and the field is advancing rapidly.

Research in this category explores whether peptides can modulate epigenetic aging clocks, clear senescent cells (cells that have ceased dividing but remain metabolically active and secrete pro-inflammatory factors), or reactivate endogenous repair mechanisms that diminish with age.

Peptides of interest include Epitalon (a synthetic tetrapeptide studied for its ability to activate telomerase and potentially influence telomere length, based on research by Vladimir Khavinson) and FOXO4-DRI (a D-retro-inverso peptide designed to disrupt the FOXO4-p53 interaction in senescent cells, potentially triggering their selective apoptosis while sparing healthy cells).

Immune Peptides

Immune peptides modulate the function of the immune system, either by enhancing immune surveillance and pathogen defense (immunostimulation) or by dampening excessive or misdirected immune responses (immunomodulation or immunosuppression). These peptides are of particular interest in the context of chronic infections, autoimmune conditions, and immunodeficiency states.

The immune system is extraordinarily complex, involving innate and adaptive arms with dozens of cell types and hundreds of signaling molecules. Peptide-based immunomodulation offers the potential for targeted intervention with fewer systemic side effects than conventional immunosuppressive drugs.

Key peptides include Thymosin Alpha-1 (a thymic peptide approved in several countries for hepatitis B and C treatment, with research into broader immunomodulatory applications including cancer immunotherapy) and KPV (a tripeptide derived from alpha-melanocyte-stimulating hormone with potent anti-inflammatory properties, studied for inflammatory bowel conditions and other inflammatory disorders).

Neuroprotective Peptides

Neuroprotective peptides promote neuronal survival, support neuroregeneration, and protect brain tissue from damage caused by ischemia, trauma, or neurodegenerative disease. This category is of immense clinical interest given the limited treatment options available for conditions such as Alzheimer's disease, Parkinson's disease, traumatic brain injury, and stroke.

These peptides may work through diverse mechanisms, including neurotrophic factor modulation, anti-apoptotic signaling, reduction of neuroinflammation, enhancement of synaptic plasticity, and promotion of neurogenesis. The blood-brain barrier presents a significant delivery challenge, and various strategies are being explored to enhance CNS penetration.

A notable peptide in this category is Cerebrolysin, a mixture of low-molecular-weight neuropeptides and free amino acids derived from porcine brain tissue. It has been studied for stroke recovery, traumatic brain injury, and neurodegenerative conditions, with clinical data from multiple trials indicating potential neurotrophic and neuroprotective effects.

Mitochondrial Peptides

Mitochondrial peptides target mitochondrial function, cellular energy production, and the oxidative stress pathways closely tied to mitochondrial health. Given that mitochondrial dysfunction is implicated in aging, neurodegenerative diseases, metabolic disorders, and cardiovascular disease, this category has broad therapeutic potential.

These peptides may directly interact with mitochondrial components (such as cardiolipin in the inner mitochondrial membrane), modulate mitochondrial biogenesis, reduce reactive oxygen species production at its source, or activate mitochondria- specific stress response pathways (mitohormesis).

Key peptides include SS-31 (also known as Elamipretide, a tetrapeptide that selectively concentrates in the inner mitochondrial membrane and binds to cardiolipin, stabilizing electron transport chain function and reducing ROS production) and MOTS-c (a mitochondria-derived peptide encoded within the mitochondrial genome itself, involved in metabolic regulation, exercise mimetic effects, and cellular stress response through AMPK activation).

Vascular Peptides

Vascular peptides influence blood vessel function, including vasodilation, angiogenesis, endothelial health, and cardiovascular regulation. These peptides are relevant to conditions ranging from erectile dysfunction and peripheral artery disease to pulmonary hypertension and wound healing (where angiogenesis is critical).

The vascular system is regulated by a complex interplay of vasodilators (nitric oxide, prostacyclin) and vasoconstrictors (endothelin, angiotensin II). Peptide- based interventions in this system can offer targeted effects on vascular tone, blood flow, and tissue perfusion.

A key peptide in this category is Alprostadil, a synthetic form of prostaglandin E1 (PGE1) that acts as a potent vasodilator. It is FDA-approved for erectile dysfunction (administered via intracavernosal injection or intraurethral suppository) and for maintaining patent ductus arteriosus in neonates with certain congenital heart defects.

Neuropeptide Modulators

Neuropeptide modulators are peptides that act within the nervous system to regulate a wide range of functions, including autonomic processes, immune-nervous system communication, circadian rhythm, gastrointestinal motility, and inflammation. These peptides often have multi-system effects, reflecting the nervous system's role as a master integrator of physiological function.

Unlike neuroprotective peptides (which primarily focus on preventing neuronal damage), neuropeptide modulators exert their effects through neuromodulation — altering the activity of neural circuits and the organs they innervate. They may function as neurotransmitters, neuromodulators, or neurohormones depending on their site of release and target.

A key peptide in this category is VIP (Vasoactive Intestinal Peptide), a 28-amino acid neuropeptide with remarkably diverse functions. VIP acts through VPAC1 and VPAC2 receptors (both GPCRs) to regulate vasodilation, immune cell function, circadian rhythm, gastrointestinal secretion, and bronchodilation. It has been investigated for conditions ranging from pulmonary hypertension to inflammatory bowel disease.

Hormonal Peptides

Hormonal peptides function within the endocrine system to regulate reproduction, metabolism, growth, and homeostasis. Many of the body's most important hormones are peptides, and synthetic analogs or modulators of these hormones have significant therapeutic applications.

The hypothalamic-pituitary axis is a major site of peptide hormone action, with hypothalamic releasing hormones controlling pituitary hormone secretion, which in turn regulates target organ function. Therapeutic peptides in this category may mimic, enhance, or suppress the activity of endogenous hormonal peptides.

A peptide of interest in this category is Kisspeptin, a peptide that acts upstream of GnRH neurons in the hypothalamus and plays a pivotal role in the initiation of puberty and the regulation of reproductive function. Kisspeptin research has expanded into areas including fertility treatment, diagnostic testing of the reproductive axis, and understanding the metabolic-reproductive interface.